BackLeap Therapeutics Overview

Leap Therapeutics Receivables

Latest receivables for LPTX: $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
↓ 100.00% YoYΔ $-55000.00 vs prior year quarter

Peer average

Loading

Leap Therapeutics Receivables History

Loading

Leap Therapeutics vs. peers: Receivables Comparison

Loading

Leap Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Leap Therapeutics (LPTX) FAQ

Leap Therapeutics (LPTX) currently reports a receivables of $0 as of March 2026. That compares with $55K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Leap Therapeutics's receivables history and peer comparisons.

Leap Therapeutics's receivables decreased from $55K to $0 — a 100.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Leap Therapeutics reported $0 in receivables as of March 2026. That compares with $55K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Leap Therapeutics, and consider following LPTX for alerts when major investors trade the stock.

Leap Therapeutics is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LPTX with unrelated industries.